The Pharma Data

DECEMBER 14, 2020

DetermaRx is a treatment stratification test that identifies stage I-IIA non-squamous NSCLC patients at high-risk of recurrence despite ostensibly curative surgery, who may benefit from the addition of chemotherapy. “We 2020 North America International Association for the Study of Lung Cancer Conference Poster. 1 Kratz et al.,

Licensing 52

Licensing Licensing Pharmaceutical Companies Treatment 52

The Pharma Data

JANUARY 18, 2021

Fox Foundation continues to fund our cutting-edge science in their mission to transform the way new Parkinson’s disease treatments are developed and tested,” says Dr. Charlotte D’Hulst, CEO & Co-Founder of Yesse Technologies, Inc. “We are thrilled that The Michael J. For more information, visit yesse.tech.

Disease 40

Disease Molecular Biology Licensing Licensing 40

The Pharma Data

JULY 29, 2021

Eisai and Biogen Present Preliminary Assessment of the Clinical Effects of Lecanemab Following 18 Months of Treatment in the Open-Label Extension of the Phase 2 Proof of Concept Study at 2021 Alzheimer’s Association International Conference (AAIC) . 42/40 ratio, brain amyloid by PET and treatment Low values of plasma A?42/40

Clinical Trials 52

Clinical Trials Treatment Clinical Development Disease 52

The Pharma Data

NOVEMBER 9, 2020

NAVIGATOR is a Phase 3, randomized, double-blinded, placebo-controlled trial in adults (18–80 years old) and adolescents (12–17 years old) with severe, uncontrolled asthma, who were receiving treatment with medium- or high-dose ICS plus at least one additional controller medication with or without OCS.

Trials 52

Trials Production Clinical Trials Government 52

The Pharma Data

OCTOBER 20, 2020

8 months in similar patients with metastatic breast cancer in the third line setting without BriaCell’s treatment; Additional overall survival data will be presented at the 2020 San Antonio Breast Cancer Symposium®, December 9 – 11. Overall Survival of 13. BERKELEY, Calif. and VANCOUVER, British Columbia, Oct.

Treatment 40

Treatment Research International Regulations 40

The Pharma Data

DECEMBER 21, 2020

“The recent results from our NAVIGATOR trial were impressive, both in terms of the overall clinical data and the reduction in exacerbation rate with tezepelumab treatment, and we continue to work with AstraZeneca on planned regulatory filings in 2021. Detailed results from the SOURCE trial will be presented at a future medical meeting.

Trials 40

Trials Production Clinical Trials Therapies 40

The Pharma Data

AUGUST 13, 2020

The Final Settlement Date for the Exchange Offers will be promptly after the Expiration Date and is currently expected to occur on August 28, 2020 , the second business day immediately following the Expiration Date. No forward-looking statement can be guaranteed and actual results may differ materially from those we project.

Production 52

Production Government Marketing Regulations 52

The Pharma Data

AUGUST 13, 2020

Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen , including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K.

Production 52

Production Government Regulations Marketing 52

Codon

APRIL 9, 2024

In response to the precipitous rise in incidence, governments on both sides of the Pacific began a systematized search for antimalarial treatments. Over the course of 12 years, the Walter Reed Army Institute of Research (WRAIR) screened more than 250,000 compounds in search of an efficacious treatment.

Drugs 141

Drugs Science Research Doctors 141

The Pharma Data

JANUARY 6, 2021

The ongoing coronavirus pandemic and the lack of treatment options for severe cases has been devastating for patients, their families and medical communities around the world,” commented Erik van den Berg , Chief Executive Officer at AM-Pharma. 7, 2021 10:00 UTC. UTRECHT, The Netherlands–( BUSINESS WIRE )– AM-Pharma B.V. ,

Trials 52

Trials Hospitals Treatment International 52

PLOS: DNA Science

APRIL 13, 2023

received treatment, according to the National Institute on Drug Abuse (NIDA). Now a report in Nature Mental Health from an international team led by researchers at Washington University in St. So scrutinizing genomes for genes that control drug dependency could inspire treatments. Environmental influences are well known.

DNA 52

DNA Drugs Treatment Science 52

Agency IQ

APRIL 19, 2024

Treatment for MM may be lifelong, with patient and disease characteristics guiding the course of treatment. Patients frequently receive up to four therapies at once and go through multiple prolonged courses of treatment to keep recurrence and progression at bay.

FDA 40

FDA Disease Trials Clinical Trials 40

The Pharma Data

APRIL 27, 2021

Roche announces five new intended uses for key cardiac biomarkers to help identify cardiovascular risk, better diagnose patients and support early treatment. Early diagnosis and treatment can contribute to saving or improving people’s lives and could help healthcare systems save money.

Treatment 40

Treatment Disease Pharmaceuticals Therapies 40

The Pharma Data

NOVEMBER 29, 2020

To access the conference call, please dial +1 877 870 9135 (from the US) or +44 2071 928338 (international) and refer to conference ID 4469307. The lead replicating arenavirus oncology product candidates, HB-201 and HB-202, are in development for the treatment of Human Papilloma Virus 16-positive cancers in a Phase 1/2 clinical trial.

Vaccine 40

Vaccine Clinical Trials Disease Therapies 40

Broad Institute

JULY 28, 2023

Notably, fragmented maternal care yields internalizing symptoms (cognitive rigidity) in female offspring, while producing externalizing consequences (attention deficits, social impairments) in male siblings. The Hensch lab has recently characterized a mouse model of parental neglect that reveals dramatic behavioral differences by sex.

Medical Schools 52

Medical Schools Hospitals Regulations Research 52

The Pharma Data

NOVEMBER 9, 2020

The Chair of the Review Committee on the functioning of the International Health Regulations (2005) during COVID-19 response , Professor Lothar H. Wieler, President of the Robert Koch Institute, Germany provided an update on the work of the Committee and its preliminary findings. billion financing gap.

Nurses 40

Nurses Vaccine Government International 40

The Pharma Data

MAY 5, 2022

Launched in 2005 to give every child an equal chance of survival, ‘My Child Matters’ provides financial support and expertise so that all children can access diagnosis and treatment. To that end, Foundation S will work to increase the health resilience of vulnerable populations most impacted by climate change and pollution.

Vaccine 52

Vaccine Treatment Hospitals International 52

The Pharma Data

DECEMBER 15, 2020

TOMI-T1D is an international partnership between academia, the pharmaceutical industry and nonprofit organizations. Critical Path Institute (C-Path) is an independent, nonprofit organization established in 2005 as a public and private partnership. For more information, please visit jdrf.org or follow us on Twitter: @JDRF.

Drug Development 40

Drug Development Clinical Trials Vaccine Trials 40

Agency IQ

MARCH 1, 2024

March 2024 Standards of Performance for New Stationary Sources and Emission Guidelines for Existing Sources: Other Solid Waste Incineration Units Review (Final Rule Stage) 2060-AU60 EPA promulgated emissions standards for Other Solid Waste Incineration (OSWI) units on December 16, 2005. On September 14, 2018, the U.S.

Regulations 40

Regulations Compliance Government Production 40

Agency IQ

JUNE 16, 2023

On March 5, 2012, environmental groups, the Association of Battery Recyclers and Johnson Controls International petitioned the Agency for reconsideration of aspects of the final rule. Amendments to TSCA in 2016 included several new provisions concerning the assertion and Agency review and treatment of CBI claims.

Regulations 40

Regulations Compliance Production Science 40

Agency IQ

MARCH 29, 2024

March 2024 Standards of Performance for New Stationary Sources and Emission Guidelines for Existing Sources: Other Solid Waste Incineration Units Review (Final Rule Stage) 2060-AU60 EPA promulgated emissions standards for Other Solid Waste Incineration (OSWI) units on December 16, 2005. On September 14, 2018, the U.S.

Regulations 40

Regulations Compliance Production Government 40

Agency IQ

DECEMBER 15, 2023

The allowance or “variance” to the prohibition on the open burning of hazardous waste was established at a time when there were no alternatives to the safe treatment of waste explosives. Units covered under this rule include certain very small municipal waste combustion and institutional waste incineration units.

Regulations 40

Regulations Compliance Production Government 40

The Pharma Data

MAY 13, 2021

You should not use the information on this site for diagnosis or treatment of any health problem or for prescription of any medication or other treatment. JAMA Intern Med. J Intern Med. A survey of the opinions of obesity experts on the causes and treatment of obesity. Food addiction-diagnosis and treatment.

Disease 52

Disease Production Testimonials Science 52

The Pharma Data

AUGUST 31, 2021

The high incidence of HIV among young women in sub-Saharan Africa reminds us that, despite great progress made in treatment and prevention, HIV remains a major health challenge for the region,” said Professor Glenda Gray, President and Chief Executive Officer, South African Medical Research Council (SAMRC) and Imbokodo’s Protocol Chair.

Vaccine 52

Vaccine Trials Virus Treatment 52

Drug & Device Law

JUNE 1, 2023

Accord Arizona State Hospital/Arizona Community Protection & Treatment Center v. 2005); In re Doe , 981 P.2d Jewish Hospital Healthcare Services , 2005 WL 2469688, at *5 (Ky. Miles , 414 P.3d 3d 680, 689 (Ariz. Klein , 296 P.3d 3d 1003, 1009 (Ariz. Gastro-Intestinal Center, Inc. , 3d 741, 748 (Ark. Bayer CropScience LP v.

Testimonials 59

Testimonials Trials Science Government 59

Drug & Device Law

DECEMBER 4, 2023

Abuse of substantive law as a weapon to force settlement occurs so frequently in multidistrict litigation (“MDL”), that we’ve given it a name – “the MDL treatment.” The linchpin of the MDL treatment is that plaintiffs are allowed to take way more liberties with state law than the Erie doctrine allows. 16, 2005); Huntman v.

Production 52

Production Trials Treatment Pharmaceuticals 52

Drug & Device Law

MAY 30, 2022

That oncologists prescribing lifesaving standard-of-care treatment in the face of “aggressive cancer” are not impressed by a risk of – permanent hair loss – is not surprising. at *3 (emphasis original). Hoffman-LaRoche, Inc. , 2d 806, 817 (5th Cir. 1992) (applying Mississippi law). 692, 694 (5th Cir. Another recent decision is Hubbard v.

Testimonials 59

Testimonials Doctors Production Laboratories 59

Drug & Device Law

JULY 31, 2023

The 2005 revisions to Article 2 excludes “information” from the definition of goods and also defines computer software as “information.” International Trade Commission , 810 F.3d 2003), an Internal Revenue Service regulation, excluded liability for “product” refund, repair or replacement. July 11, 2005), aff’d , 277 F.

Production 52

Production Trials International Government 52

Drug & Device Law

AUGUST 24, 2023

at *3 (internal quotation marks and citations omitted). M1 had read literature “pertaining to bisphosphonates,” and worked with patients taking such medications, requiring him to “understand and explain” the products’ risks and benefits—qualifying him to “opine generally regarding the diagnosis and treatment of ONJ.” Id. at *8-10.

Testimonials 52

Testimonials International Treatment Production 52

Codon

APRIL 24, 2025

1 Such data is illuminating because enrollment numbers offer a measure of the administrative burden placed on new treatments as they move from concept to real-world testing. Chinese clinical trial data has been available on the ClinicalTrials.gov platform since 2005, with the exception of multinational trials with sites in China.

Clinical Trials 127

Clinical Trials Trials Pharmaceutical Companies Licensing 127

PPD

MARCH 26, 2025

In the summer of 2005, I got a phone call that changed my life forever. If the disease progresses without treatment, the brains cerebral cortex shrinks in a process called cortical atrophy. Some patients dont respond to treatment at all, and some have a more aggressive form of MS. As of November 2024, more than 20 U.S.

Research 52

Research Clinical Research Clinical Trials Treatment 52

Alta Sciences

MARCH 4, 2025

Despite having a final FDA guidance issued in 2017 , evolving drug development and treatment modalities continue to prompt important dialogue to adapt existing methods. One example is the recent interest in psychedelics for the treatment of psychiatric disorders, including major depressive disorder.

Clinical Trials 52

Clinical Trials FDA Drug Development Trials 52

New Drug Approvals

APRIL 27, 2025

SYN Tropium chloride is one of the azoniaspironortropine derivatives and is used for the treatment of urinary bladder dysfunction due to bladder dysfunction, night urination, overactive bladder, and urinary incontinence. 31] Reference ^ Jump up to: a b “International brands of trospium” Drugs.com. Useful compounds.

FDA Approval 57

FDA Approval FDA Pharmacokinetics Licensing 57

New Drug Approvals

APRIL 23, 2025

9] Probenecid was added to the International Olympic Committee ‘s list of banned substances in January 1988, due to its use as a masking agent. [10] Butler D (November 2005). Experimental Properties Property Value Source melting point (C) 195 C PhysProp water solubility 27.1 mg/L Not Available logP 3.21 HANSCH,C ET AL.

Pharmacokinetics 62

Pharmacokinetics FDA Production Regulations 62

New Drug Approvals

MARCH 31, 2025

g/mol SCHEME Tisolagiline ( INN Tooltip International Nonproprietary Name; developmental code names KDS-2010 , SeReMABI ) is a potent , highly selective , and reversible monoamine oxidase B (MAO-B) inhibitor which is under development for the treatment of Alzheimer’s disease and obesity. [1] 1] [2] [3] [4] It is taken by mouth.

Disease 62

Disease Clinical Trials Treatment International 62

Codon

MAY 5, 2025

At the 1957 Proceedings of the International Symposium on Isotope Separation held in Amsterdam, Zippe realized that the technology he had developed alongside Steenbeck while in captivity outpaced that in the rest of the world. Developmental Biology (2005). Credit: Dahm R.

DNA 58

DNA Engineering Science Laboratories 58